For millions of women, a small pill has been the most common way to end a pregnancy at home. Now, the government is looking back to see if that pill is as safe as they once said.

WHAT HAPPENED

The FDA is starting a new review of mifepristone. This drug has been used in the U.S. for more than 20 years.

Anti-abortion groups asked for this check. The government said it is true that the study is happening now.

This move is a big win for people who want to limit access to the drug. It could lead to new rules on how the pill is sold and used.

WHAT THE EVIDENCE SHOWS

The review looks at safety data from the past.

• Mifepristone is used in over 60% of U.S. abortions.
• The FDA first gave the drug the green light in 2000.
• Groups want to stop the pill from being sent in the mail.
• A federal worker said the review is active.

THE BIGGER QUESTION

Is this review about science or about politics? We have to ask if a drug's safety should change every time a new group of people takes power.

If the data has not changed, why is the answer changing? This story is about who gets to decide what is safe for your body.

WHAT HAPPENS NOW

This could lead to new federal rules on how people get the pill. It might mean more doctor visits or a ban on getting it through the mail.

For many people, this could make it much harder to get healthcare. It may also change how other drugs are reviewed in the future.

WHAT WE STILL DON'T KNOW

How long will the safety review take?

• Will the FDA change the rules before the review is finished?
• What specific data points are they looking at this time?